LE WE PMID CA
Obesity (BASKET)62Adipositas (allg)

11 beta HSD1

2 Arachidonoylglycerol

A Zip F1 mouse

Adipokine

Adiponectin

Adipose tissue (BASKET)

Adipose tissue (Development)

Agouti

AGRP neuron

AMP activated protein kinase

Anandamide

Androgens (Hypogonadism)

Angiopoietin like factors

ANGPTL2

ANGPTL6

Anorexia nervosa

Arcuate nucleus

Arterial hypertension (BASKET)

Atherosclerosis (BASKET)

Autoantibodies Anti Melanocortin 4 receptor

Autophagy

Bariatric surgery

Cachexia (Oncology and BASKET)

Cardiovascular risk

Carnitine palmitoyltransferase deficiency

Cholecystokinin

Circadian clock

CNS (Deep brain stimulation)

Conjugated linoleic acid

Db mouse

Developmental origin of disease

Diabetes mellitus (BASKET)

Diabetes mellitus (Beta cell decay)

Dorsomedial nucleus

Drug development

DsbA L

Endocannabinoid

Endocrine disruptor

Energy expenditure

ERS UFR (Diseases)

Estrogen

Exercise (Physiology)

Eye (Diseases)

FABP1 L FABP

Fatty acids (Free)

Fructose

Genetics (Imprinting)

Ghrelin

GNAS

GnRH

Growth hormone

IAPP islet amyloid polypeptide

IGF1

IKKbeta

Inflammation (BASKET)

Inflammation homeostatic

Inflammation resolution

Insulin (resistance)

Interleukin15

Interleukin17

Ion channel (Sodium ENaC)

Ion channel (Sodium)

Kidney (Chronic renal failure)

Kisspeptin

Koletsky rat

Krox20 Egr2

Leptin

Liddle s syndrome

Lipoprotein (HDL)

Lipoxin

Liver (Steatohepatosis)

Lorcaserin

Macrophages

Metabolic syndrome

Metformin

MIF

Muscle (Physiology)

Neoplasia (Cancer survivor)

Neoplasia (Carcinogenesis)

Neoplasia (Tumor biology and immunology)

Neuropeptide Y

Nhlh2

NR1C1 PPAR alpha

Nutrition (Neuroendocrinology)

ob ob mouse

Obesity (BASKET)

Obesogen

Orlistat

Osteoporosis

Otsuka Long Evans Tokushima fatty rat OLETF rat

Paraventricular nuclei

PGC1alpha

Phentermine

Prader Willi syndrome

Prostaglandin D2

Protectin

Protein kinase R

RBP4

Receptor (Interleukin6 GP130)

Resistin

Resolvin

Reward (Neurophysiology)

Rimonabant

RMI1

Sibutramine

SIRT1

Sleep disorder

SOCS3

STAT3

Topiramate

TRPV1

TRPV4

Tubby mouse

UCP1

Ventromedial nucleus

Visfatin

Zucker rat

2006  
1
The medical complications of obesity.
[16916862] QJM 99(9): 565-79 (2006)
2006  
2
Preventing and managing pediatric obesity. Recommendations for family physicians.
[16572577] Can Fam Physician 52(): 322-8 (2006)
2007  
3
2008  
4
Orlistat in the prevention of diabetes in the obese patient.
[18561508] Vasc Health Risk Manag 4(2): 325-36 (2008)
2006  
5
Vascular risks and management of obesity in children and adolescents.
[17319462] Vasc Health Risk Manag 2(2): 171-87 (2006)
2007  
6
Pharmacological treatment of the overweight patient.
[17540905] Pharmacol Rev 59(2): 151-84 (2007)
2008  
7
Atherogenic lipid risk factors in men classified as overweight and obese according to the preliminary WHO guidelines for Asians.
[19130868] Indian J Physiol Pharmacol 52(2): 205-8 (2008)
2009  
8
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
[19726018] Health Technol Assess 13(41): 1-190, 215-357, iii-iv (2009)
2008  
9
Obesity: a review of pathogenesis and management strategies.
[18209783] Can J Gastroenterol 22(1): 61-8 (2008)
2004  
10
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity.
[15051594] Am J Clin Nutr 79(4): 537-43 (2004)
1993  
11
Mechanisms by which somatotropin decreases adipose tissue growth.
[8328402] Am J Clin Nutr 58(2 Suppl): 287S-295S (1993)
1992  
12
The role of very-low-calorie diets in obesity.
[1615890] Am J Clin Nutr 56(1 Suppl): 240S-243S (1992)
1992  
13
1992  
14
A brief overview of human energy metabolism and its relationship to essential obesity.
[1728837] Am J Clin Nutr 55(1 Suppl): 242S-245S (1992)
1979  
15
Obesity: adverse effects on health and longevity.
[389027] Am J Clin Nutr 32(12 Suppl): 2723-33 (1979)
2001  
16
Infectobesity: obesity of infectious origin.
[11584109] J Nutr 131(10): 2794S-2797S (2001)
2005  
17
Obesity: prevalence, theories, medical consequences, management, and research directions.
[18500955] J Int Soc Sports Nutr 2(): 4-31 (2005)
2004  
18
Monogenic human obesity syndromes.
[14749512] Recent Prog Horm Res 59(): 409-24 (2004)
2004  
19
2010  
20
Deep brain stimulation compared with bariatric surgery for the treatment of morbid obesity: a decision analysis study.
[20672917] Neurosurg Focus 29(2): E15 (2010)
2008  
21
2005  
22
Meta-analysis: surgical treatment of obesity.
[15809466] Ann Intern Med 142(7): 547-59 (2005)
2005  
23
Meta-analysis: pharmacologic treatment of obesity.
[15809465] Ann Intern Med 142(7): 532-46 (2005)
2008  
24
Association between depressive symptoms in childhood and adolescence and overweight in later life: review of the recent literature.
[18838652] Arch Pediatr Adolesc Med 162(10): 981-8 (2008)
2005  
25
Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment.
[15837955] Circulation 111(15): 1999-2012 (2005)
2007  
26
Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
[17699463] Clin J Am Soc Nephrol 2(3): 550-62 (2007)
2008  
27
Neurophysiological pathways to obesity: below awareness and beyond individual control.
[18586908] Diabetes 57(7): 1768-73 (2008)
2006  
28
Influence of obesity on the risk of developing colon cancer.
[16239255] Gut 55(2): 285-91 (2006)
2004  
29
New thoughts on managing obesity.
[15194659] Gut 53(7): 1044-53 (2004)
2008  
30
Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials.
[18782881] J Clin Endocrinol Metab 93(12): 4600-5 (2008)
2008  
31
Clinical review: behavioral interventions to prevent childhood obesity: a systematic review and metaanalyses of randomized trials.
[18782880] J Clin Endocrinol Metab 93(12): 4606-15 (2008)
2008  
32
Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion.
[18782869] J Clin Endocrinol Metab 93(12): 4576-99 (2008)
2008  
33
2008  
34
Adipocytokines and the metabolic complications of obesity.
[18987272] J Clin Endocrinol Metab 93(11 Suppl 1): S64-73 (2008)
2008  
35
2008  
36
2007  
37
Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
[17148564] J Clin Endocrinol Metab 92(2): 386-95 (2007)
2005  
38
2004  
39
2004  
40
2001  
41
Obesity-related glomerulopathy: an emerging epidemic.
[11260414] Kidney Int 59(4): 1498-509 (2001)
2007  
42
Evaluation and management of childhood and adolescent obesity.
[17908531] Mayo Clin Proc 82(10): 1258-64 (2007)
2007  
43
Viruses as an etiology of obesity.
[17908526] Mayo Clin Proc 82(10): 1192-8 (2007)
2007  
44
1988  
45
Obesity. Part II--Treatment.
[3074556] West J Med 149(5): 555-71 (1988)
1988  
46
Obesity. Part I--Pathogenesis.
[3067447] West J Med 149(4): 429-41 (1988)
2007  
47
Diseases associated with childhood obesity.
[17377057] AJR Am J Roentgenol 188(4): 1118-30 (2007)
2007  
48
Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children.
[17420493] CMAJ 176(8): 1103-6 (2007)
2007  
49
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary].
[17420481] CMAJ 176(8): S1-13 (2007)
2008  
50
The role of SOCS-3 protein in leptin resistance and obesity.
[18560028] Acta Med Indones 40(2): 89-95 (2008)
2009  
51
Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.
[19299892] Am J Nephrol 30(2): 140-6 (2009)
2011  
52
Respiratory complications of obesity.
[21458904] Arch Bronconeumol 47(5): 252-61 (2011)
2004  
53
Dietary supplements for body-weight reduction: a systematic review.
[15051593] Am J Clin Nutr 79(4): 529-36 (2004)
2005  
54
Survival advantages of obesity in dialysis patients.
[15755821] Am J Clin Nutr 81(3): 543-54 (2005)
2006  
55
Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult.
[16638823] Am J Physiol Endocrinol Metab 291(3): E439-40 (2006)
2006  
56
ABC of obesity. Assessment of obesity and its clinical implications.
[17008674] BMJ 333(7570): 695-8 (2006)
2006  
57
ABC of obesity. Management: Part I--behaviour change, diet, and activity.
[17023467] BMJ 333(7571): 740-3 (2006)
2006  
58
ABC of obesity. Management: Part III--surgery.
[17068036] BMJ 333(7574): 900-3 (2006)
2006  
59
ABC of obesity. Management: part II--drugs.
[17038738] BMJ 333(7572): 794-7 (2006)
2006  
60
ABC of obesity. Strategies for preventing obesity.
[17082548] BMJ 333(7575): 959-62 (2006)
2006  
61
ABC of obesity. Obesity and cancer.
[17124223] BMJ 333(7578): 1109-11 (2006)
2006  
62
ABC of obesity: obesity and vascular disease.
[17110725] BMJ 333(7577): 1060-3 (2006)
2006  
63
ABC of obesity. Risk factors for diabetes and coronary heart disease.
[17095784] BMJ 333(7576): 1009-11 (2006)
2006  
64
ABC of obesity. Childhood obesity.
[17158388] BMJ 333(7580): 1207-10 (2006)
2006  
65
ABC of obesity. Obesity and reproduction.
[17138998] BMJ 333(7579): 1159-62 (2006)
2009  
66
Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.
[19348861] Biochim Biophys Acta 1793(7): 1128-43 (2009)
2006  
67
Tending to the musculoskeletal problems of obesity.
[16970135] Cleve Clin J Med 73(9): 839-45 (2006)
2003  
68
Prevention of pediatric overweight and obesity.
[12897303] Pediatrics 112(2): 424-30 (2003)
2007  
69
Assessment of child and adolescent overweight and obesity.
[18055652] Pediatrics 120 Suppl 4(-): S193-228 (2007)
2007  
70
Recommendations for prevention of childhood obesity.
[18055653] Pediatrics 120 Suppl 4(-): S229-53 (2007)
2007  
71
Recommendations for treatment of child and adolescent overweight and obesity.
[18055654] Pediatrics 120 Suppl 4(-): S254-88 (2007)
2009  
72
Spectrum and management of hypertriglyceridemia among children in clinical practice.
[19171610] Pediatrics 123(2): 458-65 (2009)
2007  
73
Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.
[17659704] World J Gastroenterol 13(26): 3540-53 (2007)
2007  
74
2007  
75
Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
[17699878] Physiology (Bethesda) 22(-): 252-60 (2007)
2010  
76
Sympathetic activation in obesity: a noninnocent bystander.
[20625071] Hypertension 56(3): 338-40 (2010)
2002  
77
Obesity hypertension in children: a problem of epidemic proportions.
[12364344] Hypertension 40(4): 441-7 (2002)
2010  
78
Obesity, sympathetic overdrive, and hypertension: the leptin connection.
[20194295] Hypertension 55(4): 844-5 (2010)
2007  
79
Hypoadiponectinemia: a novel link between obesity and hypertension?
[17452503] Hypertension 49(6): 1217-9 (2007)
2008  
80
Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?
[18086947] Hypertension 51(2): 168-71 (2008)
2004  
81
Overview: obesity: what does it have to do with kidney disease?
[15504929] J Am Soc Nephrol 15(11): 2768-72 (2004)
2004  
82
Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?
[15504931] J Am Soc Nephrol 15(11): 2775-91 (2004)
2004  
83
The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
[15504932] J Am Soc Nephrol 15(11): 2792-800 (2004)
2003  
84
After all those fat years: renal consequences of obesity.
[14605265] Nephrol Dial Transplant 18(12): 2471-4 (2003)
2008  
85
Why is obesity associated with osteoarthritis? Insights from mouse models of obesity.
[18836239] Biorheology 45(3-4): 387-98 (2008)
2010  
86
Endoplasmic reticulum stress and inflammation in obesity and diabetes.
[20814028] Circ Res 107(5): 579-91 (2010)
2007  
87
Cardiac energy metabolism in obesity.
[17702980] Circ Res 101(4): 335-47 (2007)
2007  
88
Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals.
[17615379] Circ Res 101(1): 27-39 (2007)
2007  
89
Leptin signaling and obesity: cardiovascular consequences.
[17872473] Circ Res 101(6): 545-59 (2007)
2011  
90
Biology of obesity: lessons from animal models of obesity.
[21274264] J Biomed Biotechnol 2011(-): 197636 (2011)
2006  
91
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
[16627822] Arterioscler Thromb Vasc Biol 26(5): 968-76 (2006)
2010  
92
Epithelial Na+ channel (ENaC), hormones, and hypertension.
[20460373] J Biol Chem 285(31): 23527-31 (2010)
2010  
93
The possible role of IL-17 in obesity-associated cancer.
[21103795] ScientificWorldJournal 10(-): 2265-71 (2010)
2010  
94
Resolution of adipose tissue inflammation.
[20454765] ScientificWorldJournal 10(-): 832-56 (2010)
2006  
95
Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.
[16874931] Philos Trans R Soc Lond B Biol Sci 361(1471): 1159-85 (2006)
2006  
96
2008  
97
Role of body fat distribution and the metabolic complications of obesity.
[18987271] J Clin Endocrinol Metab 93(11 Suppl 1): S57-63 (2008)
2008  
98
Lifestyle and pharmacological approaches to weight loss: efficacy and safety.
[18987274] J Clin Endocrinol Metab 93(11 Suppl 1): S81-8 (2008)
2008  
99
2009  
100
Melanocortin-4-receptor autoantibodies: a new player in obesity.
[19261898] J Clin Endocrinol Metab 94(3): 757-9 (2009)
2010  
101
Homeostatic inflammation, an emerging concept.
[20823624] Endocr J 57(8): 657-8 (2010)
2008  
102
2009  
103
Pediatric obesity: etiology and treatment.
[19717003] Endocrinol Metab Clin North Am 38(3): 525-48 (2009)
2010  
104
Metabolism and circadian rhythms--implications for obesity.
[19854863] Endocr Rev 31(1): 1-24 (2010)
2011  
105
Ghrelin biology and its role in weight-related disorders.
[21712018] Discov Med 11(61): 521-8 (2011)
2011  
106
Genetic approaches to understanding human obesity.
[21633175] J Clin Invest 121(6): 2080-6 (2011)
2011  
107
Adipose tissue remodeling and obesity.
[21633177] J Clin Invest 121(6): 2094-101 (2011)
2011  
108
Inflammatory links between obesity and metabolic disease.
[21633179] J Clin Invest 121(6): 2111-7 (2011)
2010  
109
Metabolic effects of fructose and the worldwide increase in obesity.
[20086073] Physiol Rev 90(1): 23-46 (2010)
2008  
110
Cardiac remodeling in obesity.
[18391168] Physiol Rev 88(2): 389-419 (2008)
2010  
111
JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction.
[20371626] FASEB J 24(8): 2596-611 (2010)
2007  
112
The obesity-cancer link: lessons learned from a fatless mouse.
[17363554] Cancer Res 67(6): 2391-3 (2007)
2006  
113
Obesity in childhood and adolescence: evidence based clinical and public health perspectives.
[16822919] Postgrad Med J 82(969): 429-37 (2006)
2003  
114
Principles and practices in the management of obesity.
[12888610] Am J Respir Crit Care Med 168(3): 274-80 (2003)
2006  
115
2009  
116
Genetic variants influencing effectiveness of weight loss strategies.
[19466204] Arq Bras Endocrinol Metabol 53(2): 129-38 (2009)
2009  
117
Translational research into gut microbiota: new horizons in obesity treatment.
[19466205] Arq Bras Endocrinol Metabol 53(2): 139-44 (2009)
2009  
118
The brain is the conductor: diet-induced inflammation overlapping physiological control of body mass and metabolism.
[19466207] Arq Bras Endocrinol Metabol 53(2): 151-8 (2009)
2009  
119
2009  
120
Impact of adiposity on immunological parameters.
[19466211] Arq Bras Endocrinol Metabol 53(2): 183-9 (2009)
2009  
121
Adiposity in childhood cancer survivors: insights into obesity physiopathology.
[19466212] Arq Bras Endocrinol Metabol 53(2): 190-200 (2009)
2009  
122
Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.
[19466213] Arq Bras Endocrinol Metabol 53(2): 201-12 (2009)
2009  
123
Epidemiological and molecular mechanisms aspects linking obesity and cancer.
[19466214] Arq Bras Endocrinol Metabol 53(2): 213-26 (2009)
2009  
124
Metabolic disturbances linked to obesity: the role of impaired tissue perfusion.
[19466216] Arq Bras Endocrinol Metabol 53(2): 238-45 (2009)
2009  
125
Management of obesity in adolescents: state of art.
[19466218] Arq Bras Endocrinol Metabol 53(2): 252-61 (2009)
2009  
126
The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
[19466219] Arq Bras Endocrinol Metabol 53(2): 262-70 (2009)
2009  
127
2011  
128
2006  
129
The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies.
[16636330] CMAJ 174(9): 1293-9 (2006)
2004  
130
2011  
131
The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review.
[21247515] Health Technol Assess 15(2): 1-182 (2011)
2009  
132
Rimonabant for the treatment of overweight and obese people.
[19846024] Health Technol Assess 13 Suppl 3(-): 13-22 (2009)
2009  
133
Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity.
[19443932] Pharmacol Rep 61(2): 217-24 (2009)
2007  
134
Adolescent overweight and obesity--how best to manage in the general practice setting.
[17676183] Aust Fam Physician 36(8): 606-12 (2007)
2010  
135
Obesity in children & adolescents.
[21150012] Indian J Med Res 132(5): 598-607 (2010)
2010  
136
The adverse effects of obesity on conception and implantation.
[20395425] Reproduction 140(3): 347-64 (2010)
2007  
137
Developmental programming of obesity in mammals.
[17170060] Exp Physiol 92(2): 287-98 (2007)
2005  
138
The neurobiology of human obesity.
[16105936] Exp Physiol 90(5): 673-82 (2005)
2005  
139
Role of leptin in obesity-related hypertension.
[16105937] Exp Physiol 90(5): 683-8 (2005)
2009  
140
Medical management of obesity and its complications.
[19221667] Ann Acad Med Singapore 38(1): 22-7 (2009)
2009  
141
2009  
142
Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome.
[19433247] Mol Cell Endocrinol 304(1-2): 49-54 (2009)
2010  
143
Hormones and cytokines in childhood obesity.
[21048235] Indian Pediatr 47(10): 829-39 (2010)
2010  
144
Mediators of inflammation in obesity and its comorbidities.
[20885924] Mediators Inflamm 2010(-): - (2010)
2010  
145
The role of adipose tissue and adipokines in obesity-related inflammatory diseases.
[20671929] Mediators Inflamm 2010(-): 802078 (2010)
2010  
146
Chronic inflammation in obesity and the metabolic syndrome.
[20706689] Mediators Inflamm 2010(-): - (2010)
2010  
147
Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages.
[20508742] Mediators Inflamm 2010(-): 219583 (2010)
2010  
148
Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies.
[20508825] Mediators Inflamm 2010(-): 367838 (2010)
2010  
149
Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.
[20508843] Mediators Inflamm 2010(-): 513948 (2010)
2010  
150
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.
[20652043] Mediators Inflamm 2010(-): 174341 (2010)
2010  
151
Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.
[20224654] Mediators Inflamm 2010(-): 364957 (2010)
2010  
152
Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.
[20169173] Mediators Inflamm 2010(-): 610479 (2010)
2008  
153
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
[18401346] Nat Rev Mol Cell Biol 9(5): 367-77 (2008)
2011  
154
The biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectives.
[21177942] J Exp Biol 214(Pt 2): 206-29 (2011)
2005  
155
Surgical management of morbid obesity.
[15677820] Diabetes Care 28(2): 475-80 (2005)
2007  
156
Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach.
[17259519] Diabetes Care 30(2): 395-402 (2007)
2009  
157
Metformin for obesity in children and adolescents: a systematic review.
[19502540] Diabetes Care 32(9): 1743-5 (2009)
2008  
158
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.
[18227491] Diabetes Care 31 Suppl 2(-): S229-40 (2008)
2009  
159
Minireview: Endocannabinoids and their receptors as targets for obesity therapy.
[19372200] Endocrinology 150(6): 2531-6 (2009)
2010  
160
Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
[20707765] Expert Rev Cardiovasc Ther 8(12): 1777-801 (2010)
2011  
161
Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development.
[21438803] Expert Rev Cardiovasc Ther 9(3): 265-77 (2011)
2009  
162
Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines.
[19379057] Expert Rev Cardiovasc Ther 7(4): 337-40 (2009)
2008  
163
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
[18327995] Expert Rev Cardiovasc Ther 6(3): 343-68 (2008)
2010  
164
Scope and mechanisms of obesity-related renal disease.
[20134323] Curr Opin Nephrol Hypertens 19(3): 227-34 (2010)
2010  
165
Autophagy: roles in obesity-induced ER stress and adiponectin downregulation in adipocytes.
[20864818] Autophagy 6(8): 1196-7 (2010)
2010  
166
Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis.
[20144759] Cell 140(3): 338-48 (2010)
2008  
167
Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity.
[18854155] Cell 135(1): 61-73 (2008)
2010  
168
Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.
[20519119] Cell Metab 11(6): 467-78 (2010)
2009  
169
Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.
[19356714] Cell Metab 9(4): 327-38 (2009)
2008  
170
The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences.
[18436717] Clin Chem 54(6): 945-55 (2008)
2009  
171
Endoplasmic reticulum stress: another link between obesity and insulin resistance/inflammation?
[19246600] Diabetes 58(3): 518-9 (2009)
2009  
172
Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced beta-cell endoplasmic reticulum stress.
[19151199] Diabetes 58(4): 906-16 (2009)
2010  
173
Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.
[20534724] Endocrinology 151(8): 3577-88 (2010)
2009  
174
2009  
175
Recent progress in the genetics of common obesity.
[20002076] Br J Clin Pharmacol 68(6): 811-29 (2009)
2009  
176
Obesity treatment: novel peripheral targets.
[20002077] Br J Clin Pharmacol 68(6): 830-43 (2009)
2009  
177
New central targets for the treatment of obesity.
[20002079] Br J Clin Pharmacol 68(6): 852-60 (2009)
2011  
178
The use of serotonergic drugs to treat obesity--is there any hope?
[21448447] Drug Des Devel Ther 5(-): 95-109 (2011)
2008  
179
Adipose tissue inflammation and liver pathology in human obesity.
[19195627] Diabetes Metab 34(6 Pt 2): 658-63 (2008)
2009  
180
Role of macrophage tissue infiltration in obesity and insulin resistance.
[19539513] Diabetes Metab 35(4): 251-60 (2009)
2010  
181
Role of histone methylation and demethylation in adipogenesis and obesity.
[20592862] Organogenesis 6(1): 24-32 (2010)
2008  
182
TRPV1-null mice are protected from diet-induced obesity.
[18503767] FEBS Lett 582(15): 2257-62 (2008)
2012  
183
TRPV4 deficiency increases skeletal muscle metabolic capacity and resistance against diet-induced obesity.
[22207724] J Appl Physiol 112(7): 1223-32 (2012)
2004  
184
Surgical treatment of obesity: a review.
[14746355] J Natl Med Assoc 96(1): 61-75 (2004)
2008  
185
Cause and effect in childhood obesity: solutions for a national epidemic.
[18948638] J Am Osteopath Assoc 108(10): 545-52 (2008)
2009  
186
How physician obesity specialists use drugs to treat obesity.
[19300434] Obesity (Silver Spring) 17(9): 1730-5 (2009)
2009  
187
The stigma of obesity: a review and update.
[19165161] Obesity (Silver Spring) 17(5): 941-64 (2009)
2008  
188
Obesity-related changes in high-density lipoprotein metabolism.
[18388903] Obesity (Silver Spring) 16(6): 1152-60 (2008)
2008  
189
Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society.
[18464753] Obesity (Silver Spring) 16(6): 1161-77 (2008)
2006  
190
2011  
191
Current and future drug targets in weight management.
[21181547] Pharm Res 28(8): 1792-818 (2011)
2008  
192
Effectiveness of weight management programs in children and adolescents.
[19408967] Evid Rep Technol Assess (Full Rep) -(170): 1-308 (2008)
2011  
193
Pharmacological treatment of obesity: a public health perspective.
[21519691] Cad Saude Publica 27(3): 405, 404 (2011)
2008  
194
Childhood and adolescent obesity and adult mortality: a systematic review of cohort studies.
[18797731] Cad Saude Publica 24 Suppl 4(-): s558-68 (2008)
2011  
195
The gp130 receptor cytokine family: regulators of adipocyte development and function.
[21375496] Curr Pharm Des 17(4): 340-6 (2011)
2010  
196
Cellular bioenergetics as a target for obesity therapy.
[20514071] Nat Rev Drug Discov 9(6): 465-82 (2010)
2011  
197
Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis.
[21193735] Diabetes 60(1): 17-23 (2011)
2009  
198
SIRT1 genetic variation is related to BMI and risk of obesity.
[19741164] Diabetes 58(12): 2828-34 (2009)
2007  
199
New agents in development for the management of obesity.
[17850307] Int J Clin Pract 61(12): 2103-12 (2007)
2010  
200
2011  
201
Hedonic and incentive signals for body weight control.
[21340584] Rev Endocr Metab Disord 12(3): 141-51 (2011)
2011  
202
Predictors of weight loss and maintenance in patients treated with antiobesity drugs.
[21792322] Diabetes Metab Syndr Obes 4(-): 229-43 (2011)
2010  
203
Tackling obesity: new therapeutic agents for assisted weight loss.
[21437080] Diabetes Metab Syndr Obes 3(-): 95-112 (2010)
2010  
204
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents.
[21437083] Diabetes Metab Syndr Obes 3(-): 125-43 (2010)
2010  
205
Active video games to promote physical activity in children and youth: a systematic review.
[20603468] Arch Pediatr Adolesc Med 164(7): 664-72 (2010)
2009  
206
The role of the sympathetic nervous system in obesity-related hypertension.
[19442330] Curr Hypertens Rep 11(3): 206-11 (2009)
2008  
207
Putative environmental-endocrine disruptors and obesity: a review.
[18769210] Curr Opin Endocrinol Diabetes Obes 15(5): 403-8 (2008)
2009  
208
Obesity and kidney cancer risk in men: a meta-analysis (1992-2008).
[19537897] Asian Pac J Cancer Prev 10(2): 279-86 (2009)
2009  
209
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis.
[19320986] BMC Public Health 9(-): 88 (2009)
2010  
210
Metabolic effects of obesity: A review.
[21537431] World J Diabetes 1(3): 76-88 (2010)
2005  
211
Emerging pharmacological approaches to the treatment of obesity.
[16124937] J Pharm Pharm Sci 8(2): 259-71 (2005)
2010  
212
From monogenic to polygenic obesity: recent advances.
[20127379] Eur Child Adolesc Psychiatry 19(3): 297-310 (2010)
2008  
213
UCP1: its involvement and utility in obesity.
[19136989] Int J Obes (Lond) 32 Suppl 7(-): S32-8 (2008)
2008  
214
Inflammation and endoplasmic reticulum stress in obesity and diabetes.
[19136991] Int J Obes (Lond) 32 Suppl 7(-): S52-4 (2008)
2010  
215
The role of GNAS and other imprinted genes in the development of obesity.
[19844212] Int J Obes (Lond) 34(1): 6-17 (2010)
2007  
216
2011  
217
AMPK as Target for Intervention in Childhood and Adolescent Obesity.
[21318055] J Obes 2011(-): 252817 (2011)
2011  
218
Is there a metabolic program in the skeletal muscle of obese individuals?
[21603262] J Obes 2011(-): 250496 (2011)
2008  
219
Nhlh2: a basic helix-loop-helix transcription factor controlling physical activity.
[18815487] Exerc Sport Sci Rev 36(4): 187-92 (2008)
2010  
220
Behavioral and pharmacologic therapies for obesity.
[20680034] Nat Rev Endocrinol 6(10): 578-88 (2010)
2009  
221
Central leptin receptor action and resistance in obesity.
[20029269] J Investig Med 57(7): 789-94 (2009)
2002  
222
Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials.
[11850760] Int J Obes Relat Metab Disord 26(2): 262-73 (2002)
2009  
223
Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis.
[19389060] Obes Rev 10(3): 333-41 (2009)
2009  
224
2007  
225
A systematic review of environmental correlates of obesity-related dietary behaviors in youth.
[16861362] Health Educ Res 22(2): 203-26 (2007)
2010  
226
Association of endocrine disruptors and obesity: perspectives from epidemiological studies.
[20113374] Int J Androl 33(2): 324-32 (2010)
2008  
227
Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis.
[17784844] J Bone Miner Res 23(1): 17-29 (2008)
2010  
228
Adipose tissue-derived progenitor cells and cancer.
[21607127] World J Stem Cells 2(5): 103-13 (2010)
2010  
229
Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
[20628262] Neuroendocrinology 91(4): 302-7 (2010)
2008  
230
Meta-analysis of short sleep duration and obesity in children and adults.
[18517032] Sleep 31(5): 619-26 (2008)
2011  
231
Molecular basis of obesity: current status and future prospects.
[22043164] Curr Genomics 12(3): 154-68 (2011)
2011  
232
Prader-Willi Syndrome: Obesity due to Genomic Imprinting.
[22043168] Curr Genomics 12(3): 204-15 (2011)
2009  
233
Minireview: the case for obesogens.
[19372238] Mol Endocrinol 23(8): 1127-34 (2009)
2011  
234
Anti-ghrelin vaccine for obesity: a feasible alternative to dieting?
[21988299] Expert Rev Vaccines 10(10): 1363-5 (2011)
2011  
235
New insights into the mechanism of low high-density lipoprotein cholesterol in obesity.
[21988829] Lipids Health Dis 10(-): 176 (2011)
2010  
236
GH/IGF-I regulation in obesity--mechanisms and practical consequences in children and adults.
[20197666] Horm Res Paediatr 73(3): 153-60 (2010)
2009  
237
Leptin resistance: a prediposing factor for diet-induced obesity.
[19091915] Am J Physiol Regul Integr Comp Physiol 296(3): R493-500 (2009)
2008  
238
2008  
239
Complex genetics of obesity in mouse models.
[18435591] Annu Rev Nutr 28(-): 331-45 (2008)
2009  
240
Adipose tissue: a motor for the inflammation associated with obesity.
[19319966] IUBMB Life 61(4): 424-30 (2009)
2008  
241
Interleukin-15: a muscle-derived cytokine regulating fat-to-lean body composition.
[17709786] J Anim Sci 86(14 Suppl): E75-83 (2008)
2007  
242
Obesity, diet and risk of non-Hodgkin lymphoma.
[17337642] Cancer Epidemiol Biomarkers Prev 16(3): 392-5 (2007)
2004  
243
Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.
[14749510] Recent Prog Horm Res 59(-): 359-93 (2004)
2007  
244
Developmental exposure to endocrine disruptors and the obesity epidemic.
[17321108] Reprod Toxicol 23(3): 290-6 (2007)
2010  
245
Liver fatty acid-binding protein and obesity.
[20537520] J Nutr Biochem 21(11): 1015-32 (2010)
2010  
246
Antiobesity mechanisms of action of conjugated linoleic acid.
[19954947] J Nutr Biochem 21(3): 171-9 (2010)
2011  
247
Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents.
[21892560] Nutr Hosp 26(3): 451-7 (2011)
2010  
248
Is NAD(P)H oxidase a missing link for air pollution-enhanced obesity?
[21084700] Arterioscler Thromb Vasc Biol 30(12): 2323-4 (2010)
2010  
249
The use of lorcaserin in the management of obesity: a critical appraisal.
[21267355] Drug Des Devel Ther 5(): 1-7 (2010)
2011  
250
Adipocyte hyperplasia and RMI1 in the treatment of obesity.
[21199368] FEBS J 278(4): 565-9 (2011)
2011  
251
Hypothalamic malonyl-CoA and CPT1c in the treatment of obesity.
[21199367] FEBS J 278(4): 552-8 (2011)
2011  
252
Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases.
[21182596] FEBS J 278(4): 559-64 (2011)
PMC   
253
Therapy of obese patients with cardiovascular disease.
[23332347] Curr Opin Pharmacol 13(2):200-4 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia